Managing insomnia in older people

Journal of Pharmacy Practice and Research

Volumn 37, Issue 3, 2007, Pages 236-241

  Woodward, Michael C ^a  

^a HEIDELBERG REPATRIATION HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CHLORAL HYDRATE; CLOMETHIAZOLE; DIAZEPAM; ESZOPICLONE; FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC AGENT; HYPNOTIC SEDATIVE AGENT; INDIPLON; LORAZEPAM; MELATONIN; NEUROLEPTIC AGENT; OXAZEPAM; PARALDEHYDE; PLACEBO; TEMAZEPAM; TRYPTOPHAN; VALERIAN; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ANXIETY DISORDER; ATAXIA; BALANCE IMPAIRMENT; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DEPERSONALIZATION; DEPRESSION; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG TREATMENT FAILURE; ELDERLY CARE; HEALTH CARE PERSONNEL; HEART PALPITATION; HIP FRACTURE; HOSPITAL CARE; HUMAN; INSOMNIA; MEMORY DISORDER; MOTOR DYSFUNCTION; PERCEPTION DISORDER; PHARMACODYNAMICS; PREVALENCE; RELAXATION TRAINING; RESIDENTIAL CARE; REVIEW; RISK ASSESSMENT; SEDATION; SIDE EFFECT; SLEEP THERAPY; TREATMENT PLANNING; TREMOR; WITHDRAWAL SYNDROME;

EID: 35349030283     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2007.tb00754.x     Document Type: Review

References (104)

1. Kahn E, Fisher C. The sleep characteristics of the normal aged male. J Nerv Ment Dis 1969; 148: 477-94.
2. Kales J. Aging and sleep. In: Goldman R, Rockstein M, eds. The physiology and pathology of human aging. New York: Academic Press; 1975. p. 117-202.
3. Kahn E, Fisher C, Lieberman L. Sleep characteristics of the human aged female. Compr Psychiatry 1970; 11: 274-8.
4. Miles LE, Dement WC. Sleep and aging. Sleep 1980; 3: 119-29.
5. Morin CM, Gramling SE. Sleep patterns and aging: comparison of older adults with and without insomnia complaints. Psychol Aging 1989; 4: 290-4.
6. Webb WB. Age-related changes in sleep. Clin Geratr Med 1989; 5: 275-87.
7. Evans BD, Rogers AE. 24-hour sleep/wake patterns in healthy elderly persons. Appl Nurs Res 1994; 20: 137-64.
8. Folks DG, Fuller WC. Anxiety disorders and insomnia in geriatric patients. Psychiatric Clinic North America 1997; 20: 137-64.
9. Schmitt FA, Phillips BA, Cook YR, Berry DT, Wekstein DR. Self report on sleep symptoms in older adults: correlates of daytime sleepiness and health. Sleep 1996; 19: 59-64.
10. Ohayon MM, Carskadon MA, Guilleminault C, Vitello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004; 27: 1255-73.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington: APA; 1994.
12. Hauri PJ, Fisher MS. Insomnia. Mayo Clin Proc 1990; 65: 869-82.
13. Mellinger GD, Balten MB, Uhlentruth EH. Insomnia and its treatment. Arch Gen Psychiatry 1985; 42: 225-32.
14. Weyerer A, Dilling M. Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study. Sleep 1991; 14: 392-8.
15. Maggi S, Langlois JA, Minicuci N, Grigoletto F, Pavan M, Foley DJ, et al. Sleep complaints in community-dwelling older persons: prevalence, associated factors, and reported causes. J Am Geriatr Soc 1998; 46: 161-8.
16. Stewart R, Besset A, Bebbington P, Brugha T, Lindesay J, Jenkins R, et al. Insomnia comorbidity and impact and hypnotic use by age group in a natural survey population aged 16 to 74 years, Sleep 2006; 29: 1391-7.
17. Fetveit A, Bjorvatn B. Sleep disturbances among nursing home residents. Int J Geriatr Psychiatry 2002; 17: 604-9.
18. Frighetto L, Marra C, Bandali S, et al. An assessment of quality of sleep and the use of drug with sedating properties in hospitalised adult patients. Health Qual Life Outcomes 2004; 2: 17.
19. Jacobs JM, Cohen A, Hammerman-Rozenberg R, Stessman J. Global sleep satisfaction of older people: the Jerusalem Cohort Study. J Am Geriatr Soc 2006; 54: 325-9.
20. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6: 97-111.
21. Gooneratne NS, Weaver TE, Cater JR, Pack FM, Amer HM, Greenberg AS, et al. Functional outcomes of excessive daytime sleepiness in older adults. J Am Geriatr Soc 2003; 51: 642-9.
22. Byles JE, Mishra GD, Harris MA, Nair K. The problems of sleep for older women: changes in health outcomes. Age Ageing 2003; 32: 154-63.
23. Jelicic M, Bosma H, Ponds RW, Van Boxtel MP, Houx PJ, et al. Subjective sleep problems in later life as predictors of cognitive decline. Report from the Maastricht Aging Study (MAAS). Int J Geriatr Psychiatry 2002; 17: 73-7.
24. Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. J Am Geriatr Soc 2000; 40: 115-23.
25. Brassington GS, King AC, Bitwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64-99 years. J Am Geriatr Soc 2000; 48: 1234-40.
26. Liao S, Ferrell BA. Fatigue in an older population. J Am Geriatr Soc 2000; 48: 426-30.
27. Bursztyn M, Ginsberg G, Hammersman-Rozenberg R, Stessman J. The siesta in the elderly. Risk factor for mortality? Arch Intern Med 1999; 159: 1582-6.
28. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002; 59: 131-6.
29. Avidan AY, Fries BE, James ML, Szafara KL, Wright GT, Chervin RD. Insomnia and hypnotic use, recorded in the minimum data set, as prediction of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005; 53: 955-62.
30. Cricco M, Simonstick EM, Foley DJ. The impact of insomnia on cognitive functioning in older adults. J Am Geriatr Soc 2001; 49: 1185-9.
31. Althuis MD, Fredman L, Langenberg PW, Magaziner J. The relationship between insomnia and mortalilty among community-dwelling older women. J Am Geriatr Soc 1998; 46: 1270-3.
32. Heath AC, Kendler KS, Eaves JE, Martin NG. Evidence for genetic influence on sleep disturbance and sleep patterns in twins. Sleep 1990; 13: 318-35.
33. Asplund R. Are sleep disorders hereditary? A questionnaire survey of elderly person about themselves and their parents. Arch Gerontol Geriatr 1995; 21: 221-31.
34. Lewy AJ, Sack RL. Phase typing and bright light therapy of chronobiological sleep and mood disorders. In: Halaris A, ed. Chronobiology and psychiatric disorders. New York: Elsevier Science Publishing Co; 1987. p. 181-206.
35. Myers GL, Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neuroscience Biobehav Rev 1996; 19: 553-7.
36. Krystal AD. The effect of insomnia definitions, terminology and classifications on clinical practice. J Am Geriatr 2005 (suppl 7); 53: S258-S263.
37. McDowell JA, Mion LE, Lydon TJ, Inouye SK. A nonpharmacological sleep protocol for hospitalised older patients. J Am Geriatr Soc 1998; 46: 700-5.
38. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. J Can Med Assoc 2000; 162: 216-20.
39. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behaviour therapy and pharmacotherapy for insomnia. A randomised controlled trial and direct comparison. Arch Intern Med 2004; 164: 1888-96.
40. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioural and pharmacological therapies for late-life insomnia. JAMA 1999; 281: 991-9.
41. Petit L, Azad N, Byszewski A, Sarazan F, Power B. Non-pharmacological management of primary and secondary insomnia among older people: review of assessment tools and treatments. Age Ageing 2003; 32: 19-25.
42. Fuzhong L, Fisher J, Harmer P, Irbe D, Tearse RG, Weimer C. Tai Chi and self-rated quality of sleep and daytime sleepiness in older adults: a randomised controlled trial. J Am Geriatr Soc 2004; 52: 892-900.
43. Alessi CA, Martin JL, Webber AP, Kim EC, Harker JO, Josephson KR. Randomised, controlled trial of a nonpharmacological intervention to improve abnormal sleep/wake patterns in nursing home residents. J Am Geriatr Soc 2005; 53: 803-10.
44. Campbell SS, Dawson D, Anderson MW. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc 1993; 41: 829-36.
45. Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MR. Effect of light treatment on sleep and circadian rhythms in demented nursing home residents. J Am Geriatr Soc 2002; 50: 282-9.
46. Ouslander JG, Connell BR, Bitwise DL, Endeshaw Y, Griffiths P, Schnelle JF. A nonpharmacological intervention to improve sleep in nursing home patients: results of a controlled clinical trial. J Am Geriatr Soc 2006; 54: 38-47.
47. Everitt DE, Avorn J. Clinical decision making in the evaluation and treatment of insomnia. Am J Med 1990; 89: 357-62.
48. Magnusdottir SD, Ribacke M. Patients' knowledge and attitudes regarding sleep and hypnotics. Scand J Prim Health Care 1996; 14: 106-10.
49. Woodward M. Hypnosedatives in the elderly. A guide to appropriate use. CNS Drugs 1999; 11: 63-79.
50. Busto UE, Sproule BA, Knight K, Hermann N. Use of prescription and non-prescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol 2001; 8: 213-21.
51. Tu K, Mamdani MM, Hux JE, Tu J. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc 2001; 49: 1341-5.
52. Egan M, Moride Y, Wolfson C, Monette J. Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc 2000; 48: 811-16.
53. Conn DK, Madan R. Use of sleep-promoting medications in nursing home residents. Risk versus benefits. Drugs Aging 2006; 23: 271-87.
54. Svarstad BL, Mount JK. Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc 2001; 49: 1673-8.
55. Elliott RA, Woodward MC, Oborne CA. Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback. Intern Med J 2001; 31: 529-35.
56. Cook PJ, Flanagan R, James IM. Diazepam tolerance: effect of age, regular sedation, and alcohol. BMJ 1984; 289: 351-3.
57. Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002; 50: 1629-37.
58. Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 2000; 48: 682-5.
59. Allain H, Bentué-Ferrer D, Polard E, Akwa Y, Patat A. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly. Drugs Aging 2005; 22: 749-68.
60. Schneeweiss S, Wang PS. Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information. J Am Geriatr Soc 2005; 53: 948-54.
61. Tamblyn R, Abrahamowicz M, Du Berger R, McLeod P, Bartlett G. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005; 53: 233-41.
62. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epiodemiol 1992; 136: 873-83.
63. Gray SL, LaCroix AZ, Hanlon JT, Penninx BW, Blough DK, Leveille SG, et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006; 54: 224-30.
64. Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry 1979; 36: 103-16.
65. Nurmi-Lüthje I, Kaukonen JP, Lüthje P, Naboulsi H, Tanninen S, Kataja M, et al. Use of benzodiazepines and benzodiazepine-related drugs among 223 patients with an acute hip fracture in Finland: comparison of benzodiazepine findings in medical records and laboratory assays. Drugs Aging 2006; 23: 27-37.
66. Neutel CI, Hirdes JP, Maxwell CJ. New evidence on benzodiazepine use and falls: the time factor. Age Ageing 1996; 25: 273-8.
67. Ashton M. Guidelines for the rational use of benzodiazepines. Drugs 1994; 48: 25-40.
68. Petursson H, Lader MH. Benzodiazepine dependence. Br J Addict 1981; 75: 133-45.
69. Tyrer P. Withdrawal from hypnotic drugs. BMJ 1993; 306: 706-8.
70. Kruise WH. Problems and pitfalls on the use of benzodiazepine in the elderly. Drug Saf 1990; 5: 328-44.
71. Lader MH, Peturson H. Benzodiazepine derivatives - side effects and dangers. Biol Psychiatry 1981; 16: 1195-201.
72. Woodward MC. Hypnotics - options to help your patients stop. Aust Fam Physician 2000; 10: 939-44.
73. Petrovic M, Pevernagie D, Noortgate NV, Mariman A, Michielsen W, Afschrift M. A programme for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: success rate and effect on subjective sleep quality. Int J Geriatr Psychiatry 1999; 14: 754-60.
74. Cohen-Mansfield J, Lipson S, Werner P, Billig N, Taylor L, Woosley R. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home. Arch Intern Med 1999; 159: 1733-40.
75. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. J Can Med Assoc 2000; 162: 225-33.
76. Edinger JD, Sampson WS. A primary care 'friendly' cognitive behavioural insomnia therapy. Sleep 2003; 26: 177-81.
77. Oswald I, French C, Adam K, Gilham J. Benzodiazepine hypnotics remain effective for 24 weeks. BMJ (Clin Res Ed) 1982; 284: 860-3.
78. Hoehns HD, Perry PJ. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 1993; 12: 814-28.
79. Langtry HD, Benfield P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990; 40: 291-313.
80. Hedner J, Yaeche R, Emilien G, Farr I, Salinas E. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. Int J Geriatr Psychiatry 2000; 15: 704-12.
81. Hindmarch I, Legangneux E, Stanley N, Emegbo S, Dawson J. A double-blind placebo-controlled investigation of the residual psychomotor and cognitive effects of Zolpidem - MR in healthy elderly volunteers. J Clin Pharmacol 2006; 62: 538-45.
82. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001; 49: 1685-90.
83. Morgenthaler T, Silber M. Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med 2002; 3: 323-7.
84. McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, et al. A polysomnography study of eszopiclone in elderly patients with insomnia. Curr Med Res Opinion 2006; 22: 1633-42.
85. Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, et al. Sustained efficacy of eszopiclone over six months of nightly treatment: results of a randomised, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003; 26: 793-9.
86. Ancoli-Israel S, Richardson GS, Mangano RM. Long-term exposure to zaleplon is safe and effective in younger-elderly and older-elderly patients with primary insomnia. Sleep 2003; 26: A77.
87. Ancoli-Israel S, Richardson GS, Mangano RM, Jenkins L, Hall P, Jones WS. Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med 2005; 6: 107-13.
88. Dolder C, Nelson M, McKinsey J. Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? CNS Drugs 2007; 21: 289-405.
89. Zeitzer JM, Daniels JE, Duffy JF, Klerman EB, Shanahan TL, Dijk DJ, et al. Do plasma melatonin concentrations decline with age? Am J Med 1999; 107: 432-6.
90. Bursztajn HJ. Melatonin therapy: from benzodiazepine-dependent insomnia to authenticity and autonomy [editorial]. Arch Intern Med 1999; 159: 2393-5.
91. Baskett JJ, Broad JB, Wood PC, Duncan JR, Pledger MJ, English J, et al. Does melatonin improve sleep in older people? Age Ageing 2003; 32: 164-70.
92. Serfaty M, Kennell-Webb S, Warner J, Blizard R, Raven P. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry 2002; 17: 1120-7.
93. Mahle CD, Goggins GD, Agarwal P, Ryan E, Watson AJ. Melatonin modulates vascular smooth muscle tone. J Biol Rhythms 1997; 12: 690-6.
94. Stevinson C, Ernst E. Valerian for insomnia. A systematic review of randomised clinical trials. Sleep Med 2000; 1: 91-9.
95. McCall WV. Diagnosis and management of insomnia in older people. J Am Geriatr Soc 2005 (suppl 7); 53: S272-S277.
96. Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial. J Clin Sleep Med 2006; 2: 309-15.
97. Woodward M. Deprescribing: achieving better health outcomes for older people through reducing medication. J Pharm Pract Res 2003; 33: 323-8.
98. Woodward MC. Drug prescribing for older people - can we get it right? Aust J Ageing 1994; 13:27.
99. Elliott RA, Woodward MC, Oborne CA. Quality of prescribing for elderly inpatients at nine hospitals in Victoria, Australia. J Pharm Pract Res 2003; 33: 101-5.
100. Batty GM, Oborne CA, Swift CG, Jackson SH. Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical inpatients. Int J Geriatr Psychiatry 2000; 15: 892-6.
101. Griffith DN, Robinson M. Prescribing practice and policy for hypnotics: a model of pharmacy audit. Age Ageing 1996; 25: 490-2.
102. Weintraub M, Singh S, Byrne L, Maharaj K, Guttmacher L. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulators. JAMA 1991; 266: 2392-7.
103. Shader RJ, Greenblatt DJ, Balter MB. Appropriate clinical use and regulatory control of benzodiazepines. J Clin Pharmacol 1991; 31: 781-4.
104. Agostini JV, Zhang Y, Inouye S. Use of a computer-based reminder to improve sedative-hypnotic prescribing in older hospitalised patients. J Am Geriatr Soc 2007; 55: 43-8.